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stances may have on changes in bone den-
sity. These findings could play a signifi-
cant role in the development ofearly inter-
vention strategies for women with osteo-
porosis. In addition, clinical trials are
beginning at NIEHS to determine if
pathologic conditions that modify endoge-
nous estrogen levels and disrupt a normal
pubertal period (such as precocious puber-
ty or Turner syndrome) might also influ-
ence bone density at later stages of life.
The health and monetary costs of osteo-
porosis to our society are already enor-
mous, estimated at $7-10 billion annually
and affecting approximately 24 million
Americans, the majority of whom are
women. An estimated 50% of women
over age 45 and 90% of women over age
75 have osteoporosis. As the average age of
our society increases, the number ofpeople
afflicted with this disease will rise, resulting
in increased health care costs. Expanded
research in this area will extend our under-
standing from basic research studies to
clinical investigations and affected human
populations.
NIEHS to Play Unique Role in
Women's Health Research Effort
Human disease is largely the product of
the interaction between two factors, genet-
ics and the environment, throughout the
life span. Any large-scale research agenda
pertaining to human health must therefore
consider the entire life span, and it is clear
that women's health is worse over the
course of a life time than men's. It is
equally apparent that the environmental
component of this interaction has been
somewhat neglected by the biomedical
research community. A major research ini-
tiative addressing the environment and
women's health is therefore imperative.
The proposed initiative thus focuses on
hormonal carcinogenesis and endocrine
toxicology, with special emphasis on the
genetic and epigenetic molecular mecha-
nisms that underlie these phenomena.
With NIEHS's background, knowl-
edge, and ongoing research programs in
wom-en's health and insofar as a wide
range ofenvironmental agents possess hor-
monal potential and a significant percent-
age of women's health problems appear
related to dysfunction in hormonal path-
ways, this approach is likely to succeed.
Inclusion of the NIEHS extramural
(grants) component in the above areas will
undoubtedly facilitate research progress.
The diverse strengths ofextramurally fund-
ed research programs allow for important
health problems with an environmental
component, such as cardiovascular disease,
to be ad-dressed. Such a dual effort of the
NIEHS intramural and extramural re-
search programs will allow a comprehen-
sive, multidisciplinary, and inclusive
approach to this problem.
Contributing to this report on women's
health were Jeff Boyd, Laboratory ofMolecular
Carcinogenesis; J. Carl Barrett, Environmental
Carcinogenesis Program; Terri Damstra,
Program Coordination; and John McLachlan,
Office ofthe Director.
Minority Health Research
Treatment of lead toxicity, environmental
justice, and environmental health sciences
centers are among the minority health
issues that will be addressed through an
agreement between the National Institutes
ofHealth's Office ofResearch on Minority
Health (ORMH), and NIEHS. A memo-
randum of agreement between the two
NIH organizations provides NIEHS with
$5 million a year through 1997 to address
minority health concerns related to envi-
ronmental health.
John Ruffin, director of ORMH, and
Kenneth Olden, director of NIEHS,
signed the agreement March 29 at NIEHS
in Research Triangle Park, North Caro-
lina. The ORMH was established in 1990
to strengthen the efforts of NIH to im-
prove the health status of minority Amer-
icans through biomedical research and to
increase the participation of minorities in
biomedical research.
Funds provided through the agreement
will be apportioned between research pro-
grams relating to minority health and plan-
ning and research on issues ofenvironmen-
tal justice. Environmental justice addresses
pollution and environmental health risks
and their distribution across socioeconom-
ic classes and racial groups. Four major
efforts under the agreement are:
* Blood levels in children. Three to four
million children in the United States
have elevated blood lead levels. There are
two possible interventions to reduce the
problem. One is to reduce exposure
including lead abatement in homes, but
this will require years to accomplish. A
more immediate approach is to treat chil-
dren with a drug (chelating agent) that
will remove lead from the body.
Succimer is a new drug that holds
promise but has not been adequately test-
ed clinically for this purpose; it is the first
newly approved drug of its type (chelat-
ing agent) since 1950. NIEHS will sup-
port a clinical trial to establish the effec-
tiveness ofsuccimer. It is orally adminis-
tered, appears to be relatively safe, and
does not cause as much loss of necessary
elements such as zinc and iron as other
chelators. Contracts to conduct the trials
will be awarded in the next several
months.
* Lead in pregnant women. Research will
be conducted to learn to what extent the
release oflead stored in bone is increased
during pregnancy. This is an important
question in understanding how the devel-
oping fetus may be exposed through lead
exposure ofthe mother before pregnancy.
The research will focus on women from
Eastern Europe who were heavily
exposed to lead who have and then
migrated to Australia. This population
provides a unique opportunity for this
kind ofstudy because ofthe recognizable
differences in the nature of the lead iso-
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Focus on minority health. John Ruffin (left), director of the Office of Research on Minority Health, and
Kenneth Olden, director of NIEHS, sign a five-year agreement.
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